MedicaidPrior AuthLow impact
MAB2025111306
Pennsylvania Medicaid (DHS)·PA · Gastroenterology, Internal Medicine, Family Medicine +1 more·Provider Bulletin
Effective date
Jan 5, 2026
We identified it
Jun 20, 2026
Summary
Pennsylvania Medicaid is removing prior authorization guidelines for Ocaliva (obeticholic acid) from their Hepatic and Biliary Agents requirements due to the drug's voluntary withdrawal from the US market. All other prior authorization requirements for hepatic and biliary medications remain unchanged.
Action Required
By January 5, 2026: Remove any prior authorization requirements for Ocaliva (obeticholic acid) from billing workflows and systems for Pennsylvania Medicaid patients. This drug is no longer available in the US market. All other hepatic and biliary agent prior authorization procedures remain the same.